256 related articles for article (PubMed ID: 27976566)
1. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin.
Vehapoğlu A; Göknar N; Tuna R; Çakır FB
Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566
[TBL] [Abstract][Full Text] [Related]
2. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma.
Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC
Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608
[TBL] [Abstract][Full Text] [Related]
3. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone-induced drug reaction mimicking acute splenic sequestration crisis in a child with hemoglobin SC disease.
Van Buren NL; Gorlin JB; Reed RC; Gottschall JL; Nelson SC
Transfusion; 2018 Apr; 58(4):879-883. PubMed ID: 29473172
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-induced immune hemolytic anemia.
Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
[TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
Northrop MS; Agarwal HS
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
[TBL] [Abstract][Full Text] [Related]
7. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
[TBL] [Abstract][Full Text] [Related]
9. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine.
Kim S; Song KS; Kim HO; Lee HM
Yonsei Med J; 2002 Jun; 43(3):391-4. PubMed ID: 12089751
[TBL] [Abstract][Full Text] [Related]
11. Fatal immune haemolysis due to a degradation product of ceftriaxone.
Meyer O; Hackstein H; Hoppe B; Göbel FJ; Bein G; Salama A
Br J Haematol; 1999 Jun; 105(4):1084-5. PubMed ID: 10554824
[TBL] [Abstract][Full Text] [Related]
12. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
[TBL] [Abstract][Full Text] [Related]
14. Severe drug-induced immune hemolysis due to ceftriaxone.
Dara RC; Sharma R; Bhardwaj H
Asian J Transfus Sci; 2020; 14(2):187-191. PubMed ID: 33767548
[TBL] [Abstract][Full Text] [Related]
15. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'.
De Wilde M; Speeckaert M; Callens R; Van Biesen W
Acta Clin Belg; 2017 Apr; 72(2):133-137. PubMed ID: 27169474
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
Perm J; 2020; 24():. PubMed ID: 31905339
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone-induced hemolysis.
Guleria VS; Sharma N; Amitabh S; Nair V
Indian J Pharmacol; 2013; 45(5):530-1. PubMed ID: 24130395
[TBL] [Abstract][Full Text] [Related]
18. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
Garratty G; Postoway N; Schwellenbach J; McMahill PC
Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
[TBL] [Abstract][Full Text] [Related]
19. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry.
Kakaiya R; Cseri J; Smith S; Silberman S; Rubinas TC; Hoffstadter A
Arch Pathol Lab Med; 2004 Aug; 128(8):905-7. PubMed ID: 15270609
[TBL] [Abstract][Full Text] [Related]
20. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
